These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2509201)

  • 1. Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.
    Matsuoka T; Miyakoshi S; Tanzawa K; Nakahara K; Hosobuchi M; Serizawa N
    Eur J Biochem; 1989 Oct; 184(3):707-13. PubMed ID: 2509201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Serizawa N; Matsuoka T
    Biochim Biophys Acta; 1991 Jun; 1084(1):35-40. PubMed ID: 1905157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, characterization and expression of the gene encoding cytochrome P-450sca-2 from Streptomyces carbophilus involved in production of pravastatin, a specific HMG-CoA reductase inhibitor.
    Watanabe I; Nara F; Serizawa N
    Gene; 1995 Sep; 163(1):81-5. PubMed ID: 7557483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization and preliminary X-ray diffraction analysis of cytochrome P450sca-2 from Streptomyces carbophilus involved in production of pravastatin sodium, a tissue-selective inhibitor of HMG-CoA reductase.
    Ito S; Matsuoka T; Watanabe I; Kagasaki T; Serizawa N; Hata T
    Acta Crystallogr D Biol Crystallogr; 1999 Jun; 55(Pt 6):1209-11. PubMed ID: 10329788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxylation of Compactin (ML-236B) by CYP105D7 (SAV_7469) from
    Yao Q; Ma L; Liu L; Ikeda H; Fushinobu S; Li S; Xu LH
    J Microbiol Biotechnol; 2017 May; 27(5):956-964. PubMed ID: 28274099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular approaches for production of pravastatin, a HMG-CoA reductase inhibitor: transcriptional regulation of the cytochrome p450sca gene from Streptomyces carbophilus by ML-236B sodium salt and phenobarbital.
    Watanabe I; Serizawa N
    Gene; 1998 Mar; 210(1):109-16. PubMed ID: 9524240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and molecular approaches for production of pravastatin, a potent cholesterol-lowering drug.
    Serizawa N
    Biotechnol Annu Rev; 1996; 2():373-89. PubMed ID: 9704102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of dihydroxy derivative of ML-236B from ML-236B (compactin) by lipid peroxidation.
    Serizawa N; Nakahara K; Matsuoka T
    J Antibiot (Tokyo); 1990 Aug; 43(8):1031-3. PubMed ID: 2120167
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research and development of pravastatin].
    Kishida Y; Naito A; Iwado S; Terahara A; Tsujita Y
    Yakugaku Zasshi; 1991 Sep; 111(9):469-87. PubMed ID: 1762049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of computer to monitoring and control of fermentation process: Microbial conversion of ML-236B Na to pravastatin.
    Hosobuchi M; Kurosawa K; Yoshikawa H
    Biotechnol Bioeng; 1993 Sep; 42(7):815-20. PubMed ID: 18613128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial hydroxylation of compactin (ML-236B) and monacolin K.
    Yamashita H; Tsubokawa S; Endo A
    J Antibiot (Tokyo); 1985 May; 38(5):605-9. PubMed ID: 4040510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial hydroxylation of ML-236B (compactin). Studies on microorganisms capable of 3 beta-hydroxylation of ML-236B.
    Serizawa N; Serizawa S; Nakagawa K; Furuya K; Okazaki T; Terahara A
    J Antibiot (Tokyo); 1983 Jul; 36(7):887-91. PubMed ID: 6684108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6 alpha-Hydroxy-iso-ML-236B (6 alpha-hydroxy-iso-compactin) and ML-236A, microbial transformation products of ML-236B.
    Serizawa N; Nakagawa K; Tsujita Y; Terahara A; Kuwano H; Tanaka M
    J Antibiot (Tokyo); 1983 Jul; 36(7):918-20. PubMed ID: 6549610
    [No Abstract]   [Full Text] [Related]  

  • 15. A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236b(compactin) in isolated rat hepatocytes.
    Koizumi J; Mabuchi H; Takeda R; Okamoto H
    Biochem Biophys Res Commun; 1982 Sep; 108(1):240-6. PubMed ID: 7150285
    [No Abstract]   [Full Text] [Related]  

  • 16. Overaccumulation of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase in a compactin(ML-236B)-resistant mouse cell line with defects in the regulation of its activity.
    Hasumi K; Yamada A; Shimizu Y; Endo A
    Eur J Biochem; 1987 May; 164(3):547-52. PubMed ID: 3569277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
    Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
    Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and characterization of an ML-236B (compactin) biosynthetic gene cluster in Penicillium citrinum.
    Abe Y; Suzuki T; Ono C; Iwamoto K; Hosobuchi M; Yoshikawa H
    Mol Genet Genomics; 2002 Jul; 267(5):636-46. PubMed ID: 12172803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin.
    Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Baner K; Benet LZ; Sewing KF; Christians U
    J Pharmacol Exp Ther; 1999 Oct; 291(1):131-9. PubMed ID: 10490896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.